Related Experiment Videos

The epidermal growth factor receptor modulates the interaction of E-cadherin with the actin cytoskeleton

R B Hazan1, L Norton

  • 1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. rhazan@smtplink.mssm.edu

Insights

Epidermal Growth Factor Receptor (EGFR) signaling disrupts E-cadherin-mediated cell adhesion by altering cytoskeletal connections. Inhibiting EGFR restores cell-cell adhesion, highlighting its role in tumor progression.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Alterations in cell adhesion and proliferation molecules are critical for tumor progression.
  • Loss of E-cadherin and increased epidermal growth factor receptor (EGFR) expression are linked to tumorigenesis.

Purpose of the Study:

  • To investigate the regulation of E-cadherin-dependent cell adhesion by epidermal growth factor (EGF) in MDA-MB-468 human breast cancer cells.
  • To elucidate the molecular mechanisms underlying EGFR's influence on cell-cell adhesion and the actin cytoskeleton.

Main Methods:

  • Examined changes in subcellular distribution of proteins connecting E-cadherin to the actin cytoskeleton.
  • Utilized serum withdrawal, EGF treatment, function-blocking antibodies, and EGFR kinase inhibitors.
  • Assessed E-cadherin-dependent cell aggregation and protein-protein interactions via co-precipitation.

Main Results:

  • Serum withdrawal enhanced E-cadherin-mediated cell aggregation and actin-cytoskeletal component interactions in MDA-MB-468 cells.
  • EGF treatment inhibited aggregation, dissociated actin and associated proteins from E-cadherin complexes, and induced tyrosine phosphorylation of catenins.
  • EGFR inactivation mimicked serum withdrawal effects, restoring cell aggregation and cytoskeletal complex assembly.

Conclusions:

  • EGFR directly regulates cell-cell adhesion by modulating E-cadherin's interaction with the actin cytoskeleton.
  • The findings support a coordinated role for EGFR and E-cadherin in tumor progression and metastasis.

Related Concept Videos